{
  "documentMetadata": {
    "title": "Febrile Infant, Neonatal Sepsis",
    "lastUpdated": "2023-09-05",
    "sourceFile": "Febrile Infant, Neonatal Sepsis.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 2,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Fever > 38.0 C in infants 1-29 days and children 30-89 days",
        "Serious bacterial infection (SBI), e.g., UTI, bacteremia, or meningitis present in about 7-11%",
        "Most SBI are UTI (7-9%); bacteremia (1-2%), meningitis (0.5%) Risk decreases with each week of life",
        "Low risk criteria (age >29 days, WBC <15,000, Urine WBC < 10/hpf, CSF WBC < 10) identify group with ~3% chance of SBI",
        "Diagnosis & Evaluation",
        "Several approaches stratify risk",
        "Use risk calculator based on clinical features, WBC, ANC, procalcitonin and UA. [JAMA Pediatr. 2019 Apr 1;173(4):342-351](https://jamanetwork.com/journals/jamapediatrics/fullarticle/2724328).",
        "Stratify by appearance, age, WBC, ANC and enterovirus PCR and respiratory viral studies.[Pediatrics 130:e16, 2012](https://publications.aap.org/pediatrics/article/130/1/e16/30109/Febrile-Infants-Aged-29-to-90-Days-A-New-Algorithm).",
        "Perform blood culture, urine culture; enterovirus PCR and respiratory viral studies for high risk infants.",
        "Inflammatory markers CRP and procalcitonin further stratify risk. Procalcitonin is the most accurate for risk stratification if available",
        "UTI is the most common bacterial infection.",
        "Detecting viral cause, e.g., enterovirus, respiratory virus other than rhinovirus, further lowers risk of SBI in high risk: ~ 5% if high risk and virus positive; ~17% if HR and virus negative. Detection of rhinovirus does not lower risk to a similar degree ([Pediatrics 113:1662, 2004](https://publications.aap.org/pediatrics/article/113/6/1662/65919/The-Febrile-Infant-The-Role-of-Viral-Testing), [Pediatrics. 2018 Feb;141(2)](https://publications.aap.org/pediatrics/article/141/2/e20172502/37399/Rhinovirus-in-Febrile-Infants-and-Risk-of-Serious)).",
        "The role of viral testing is uncertain when procalcitonin is available",
        "Consider risk factors and clues for HSV: Genital lesions in mother 48 hours before to 48 hours after delivery, vessicles, mucosal ulcers, seizures, transaminitis, hypothermia in infant",
        "Recommended HSV studies:CSF PCR; HSV blood PCR; HSV surface swabs of the mouth, nasopharynx, conjunctivae, and anus for an HSV culture (if available) or PCR assay; alanine aminotransferase."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Etiologies have changed over time due to maternal screening, vaccinations and food safety",
        "Viral (most common):",
        "Enterovirus",
        "RSV",
        "Influenza",
        "hMPV",
        "Adenovirus",
        "Parainfluenza virus",
        "HSV rare but extremely serious. Consider especially if vesicular skin lesions, transaminitis, seizures, or CSF pleocytosis or failure to improve",
        "Bacterial causes:",
        "UTI (most common): E. coli, Group B Strep (GBS), Klebisella, Enterococcus, other Enterobacteraciae",
        "Bacteremia: E. coli, GBS, Enterococcus, other Enterobacteraciae, rarely Listeria",
        "Meningitis: GBS, E. coli, pneumococcus, meningococcus, rarely Listeria"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Primary Regimens"
    },
    {
      "type": "list",
      "items": [
        "For bacterial causes:",
        "Age <29 days: (Ceftriaxone 75-100 mg/kg/day once daily in term infants without hyperbilirubinemia or Cefotaxime 200 mg/kg/d div q6h (where available outside the US) or Ampicillin 200 mg/kg/day div q6h) + Gentamicin 5 mg/kg/day once daily",
        "Age >29 days: Ceftriaxone 75-100 mg/kg/day once daily until cultures negative at 24-36 hours if low risk",
        "Observation alone can be considered for low risk infants >29 days with normal UA, normal inflammatory markers +/- normal LP",
        "If risk factors for HSV, initiate acyclovir 60 mg/kg/day div q 8h and send HSV studies. Discontinue if studies are negative",
        "Above adapted from [Pediatrics. 2021 Aug;148(2):e2021052228](https://publications.aap.org/pediatrics/article/148/2/e2021052228/180837/Clinical-Practice-Guideline-Evaluation-and)"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Alternative Regimens"
    },
    {
      "type": "list",
      "items": [
        "Ampicillin and Gentamicin. Once considered gold standard but may not be adequate for E. coli, Klebsiella or other Enterobacteraciae given emergence of resistance. Need susceptibility data."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Consider observation without antibiotics for patients at low risk given that viral causes are the most common etiologies.",
        "Using evidence-based algorithm, infants at low risk of SBI can be safely sent home when blood culture is negative at 24 hours ([Pediatrics 130:e16, 2012](https://publications.aap.org/pediatrics/article/130/1/e16/30109/Febrile-Infants-Aged-29-to-90-Days-A-New-Algorithm))."
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Complex and evolving field. Not all diagnostic modalities are available in all settings",
        "AAP Clinical Practice Guideline [Pediatrics. 2021 Aug;148(2):e2021052228](https://publications.aap.org/pediatrics/article/148/2/e2021052228/180837/Clinical-Practice-Guideline-Evaluation-and)",
        "Review: [Pediatrics. 2018 Dec;142(6)](https://publications.aap.org/pediatrics/article/142/6/e20182849/37412/Updates-on-the-Management-of-Febrile-Infants); [Infect Dis Clin North Am 2015 Jul 16](https://www.sciencedirect.com/science/article/pii/S089155201500048X); [Infect Dis Clin North Am 29:575, 2015](https://www.sciencedirect.com/science/article/pii/S089155201500048X).",
        "Ceftriaxone is contraindicated in neonates if they require (or are expected to require) treatment with calcium-containing IV solutions, including continuous calcium-containing infusions such as total parenteral nutrition"
      ]
    }
  ]
}
